F, H., & R, S. (2026). Critical analysis of withdrawn drug applications in marketing authorization procedures of the European Medicines Agency (EMA) 2006-2024. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05443-1
Chicago Style (17th ed.) CitationF, Hitsch, and Seifert R. "Critical Analysis of Withdrawn Drug Applications in Marketing Authorization Procedures of the European Medicines Agency (EMA) 2006-2024." Naunyn-Schmiedeberg's Archives of Pharmacology 2026. https://doi.org/10.1007/s00210-026-05443-1.
MLA (9th ed.) CitationF, Hitsch, and Seifert R. "Critical Analysis of Withdrawn Drug Applications in Marketing Authorization Procedures of the European Medicines Agency (EMA) 2006-2024." Naunyn-Schmiedeberg's Archives of Pharmacology, 2026, https://doi.org/10.1007/s00210-026-05443-1.